Customers Bancorp Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Customers Bancorp Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||
net income | 60,939,000 | 12,912,000 | 56,246,000 | 50,515,000 | 22,717,000 | 3,100,000 | 27,526,000 | 27,066,000 | 9,295,000 | 15,440,000 | 17,862,000 | 6,029,000 | 23,662,000 | 24,142,000 | 21,615,000 | 21,189,000 | 19,430,000 | 17,699,000 | 15,289,000 | 11,556,000 | 13,952,000 | 8,268,000 | 8,226,000 | 7,189,000 | 6,504,000 | 3,112,000 | 3,228,000 | |||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||
benefit from credit losses | 20,781,000 | 28,297,000 | 21,194,000 | 17,066,000 | 18,121,000 | 17,070,000 | 13,523,000 | 17,856,000 | ||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 11,643,000 | 15,639,000 | 9,094,000 | 9,749,000 | 6,463,000 | 8,246,000 | 7,587,000 | 7,657,000 | 7,736,000 | 8,833,000 | 7,130,000 | 6,700,000 | 7,272,000 | 6,055,000 | 5,446,000 | 5,486,000 | 5,414,000 | 5,321,000 | 7,980,000 | 7,548,000 | 7,603,000 | 7,406,000 | 7,712,000 | 6,283,000 | 4,597,000 | 4,287,000 | 3,922,000 | 3,519,000 | 3,372,000 | 3,344,000 | 3,325,000 | |||||||||||||||||
share-based compensation expense | 4,406,000 | 4,246,000 | 3,713,000 | 3,651,000 | 3,181,000 | 3,890,000 | 2,537,000 | 3,530,000 | 3,513,000 | 3,005,000 | 3,448,000 | 3,351,000 | 3,633,000 | 3,718,000 | 2,666,000 | 3,549,000 | 4,563,000 | 3,082,000 | 3,409,000 | 2,196,000 | 3,815,000 | 3,463,000 | 2,562,000 | 2,389,000 | 2,519,000 | 2,381,000 | 3,145,000 | 2,211,000 | 2,166,000 | 2,218,000 | 1,790,000 | |||||||||||||||||
deferred taxes | 13,968,000 | -24,941,000 | -446,000 | -168,000 | -253,000 | -276,000 | 178,000 | 19,233,000 | -15,890,000 | 18,656,000 | 7,343,000 | 18,366,000 | 4,008,000 | -22,810,000 | 10,703,000 | 3,557,000 | 9,692,000 | -6,198,000 | 8,222,000 | 1,916,000 | -5,817,000 | -22,287,000 | 5,815,000 | 9,382,000 | -2,559,000 | 1,878,000 | 3,065,000 | 2,066,000 | 1,488,000 | 2,684,000 | 14,534,000 | 2,874,000 | -2,304,000 | -284,000 | -2,821,000 | -2,598,000 | 573,000 | -4,104,000 | -1,936,000 | -1,540,000 | -6,000 | 0 | 1,000 | -1,300,000 | 1,000 | 187,000 | ||
net amortization (accretion) of investment securities premiums and discounts | -1,048,000 | -725,000 | -1,202,000 | 1,408,000 | -2,403,000 | -2,286,000 | -2,723,000 | -3,081,000 | -3,096,000 | -2,682,000 | -657,000 | 425,000 | 796,000 | 918,000 | 713,000 | 722,000 | 463,000 | -14,000 | 6,000 | -85,000 | -615,000 | 251,000 | 2,704,000 | 154,000 | 39,000 | |||||||||||||||||||||||
unrealized (gain) loss on investment securities | 0 | -160,000 | 418,000 | -393,000 | 24,000 | 45,000 | -259,000 | -62,000 | -28,000 | 259,000 | 203,000 | 276,000 | 0 | 0 | -1,746,000 | -974,000 | -1,387,000 | -238,000 | -1,200,000 | 1,378,000 | -311,000 | |||||||||||||||||||||||||||
impairment loss on debt securities | ||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss on equity securities | ||||||||||||||||||||||||||||||||||||||||||||||||
net (gain) loss on sale of investment securities | 26,260,000 | 0 | 719,000 | 30,000 | 145,000 | |||||||||||||||||||||||||||||||||||||||||||
unrealized gain on equity method investments | -389,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
unrealized (gain) loss on derivatives | -802,000 | -712,000 | -767,000 | -369,000 | -59,000 | -661,000 | -205,000 | -191,000 | 52,000 | -43,000 | -563,000 | -821,000 | -964,000 | -586,000 | -524,000 | 439,000 | -2,537,000 | |||||||||||||||||||||||||||||||
(gain) loss on sale of leased assets under lessor operating leases | -33,000 | 237,000 | 33,000 | 631,000 | ||||||||||||||||||||||||||||||||||||||||||||
fair value adjustment on loans held for sale | -289,000 | 667,000 | 147,000 | 0 | 0 | 0 | -1,115,000 | |||||||||||||||||||||||||||||||||||||||||
fair value adjustment on loans held for investment | ||||||||||||||||||||||||||||||||||||||||||||||||
net (gain) loss on sale of loans and leases | 0 | -2,000 | 852,000 | |||||||||||||||||||||||||||||||||||||||||||||
origination and purchases of loans held for sale | -118,000,000 | -299,808,000 | -327,040,000 | -339,225,000 | -354,311,000 | -340,536,000 | -336,264,000 | -160,728,000 | -123,671,000 | -185,919,000 | ||||||||||||||||||||||||||||||||||||||
proceeds from the sales and repayments of loans held for sale | 139,815,000 | 326,356,000 | 396,157,000 | 296,522,000 | 333,336,000 | 322,413,000 | 145,621,000 | 141,182,000 | 207,539,000 | 106,146,000 | ||||||||||||||||||||||||||||||||||||||
amortization (accretion) of loan net deferred fees, discounts and premiums | -7,251,000 | -4,365,000 | -5,906,000 | -4,771,000 | -9,442,000 | -7,367,000 | -16,565,000 | -41,842,000 | -9,135,000 | -23,039,000 | -3,914,000 | -9,162,000 | -12,532,000 | -27,907,000 | -73,046,000 | |||||||||||||||||||||||||||||||||
earnings on investment in bank-owned life insurance | -2,249,000 | -4,660,000 | -2,125,000 | -2,049,000 | -2,007,000 | -3,261,000 | -2,160,000 | -1,973,000 | -4,997,000 | -2,647,000 | -1,975,000 | -3,449,000 | -1,947,000 | -8,326,000 | -1,984,000 | -1,988,000 | -2,765,000 | -1,679,000 | -1,744,000 | -1,746,000 | -1,757,000 | -1,762,000 | -1,795,000 | -1,824,000 | -1,837,000 | -1,816,000 | -1,851,000 | -1,869,000 | -1,869,000 | -2,031,000 | -1,922,000 | -1,673,000 | -2,257,000 | -1,367,000 | -1,386,000 | -1,120,000 | -1,123,000 | -1,177,000 | -1,169,000 | -1,061,000 | ||||||||
increase in accrued interest receivable and other assets | 13,935,000 | -10,470,000 | -43,606,000 | -12,483,000 | -33,312,000 | -10,576,000 | 22,667,000 | 71,735,000 | -69,886,000 | -932,000 | -20,474,000 | -35,643,000 | -14,329,000 | 66,855,000 | 1,064,000 | -10,248,000 | 34,860,000 | 20,979,000 | 28,545,000 | -16,053,000 | -14,469,000 | -93,856,000 | -4,842,000 | -15,988,000 | -35,202,000 | -28,109,000 | -13,089,000 | -13,668,000 | -1,051,000 | -6,806,000 | -4,394,000 | -17,244,000 | -2,824,000 | -7,794,000 | -7,471,000 | -9,897,000 | -21,304,000 | -3,259,000 | -396,000 | -3,316,000 | -176,000 | -174,000 | ||||||
increase in accrued interest payable and other liabilities | 25,917,000 | 528,000 | 28,440,000 | -6,547,000 | 480,000 | -55,207,000 | -14,659,000 | -5,126,000 | 20,401,000 | 18,064,000 | -37,074,000 | 45,764,000 | -23,244,000 | -6,440,000 | -33,310,000 | 21,193,000 | -20,577,000 | 135,679,000 | -43,179,000 | -6,665,000 | 49,301,000 | 39,004,000 | -300,000 | -1,200,000 | 21,598,000 | -5,096,000 | -15,893,000 | 12,713,000 | 5,714,000 | 7,347,000 | -2,581,000 | -4,920,000 | -5,971,000 | -3,215,000 | 52,341,000 | 10,539,000 | 4,254,000 | 3,574,000 | 778,000 | |||||||||
net cash from operating activities | 162,154,000 | 94,121,000 | 133,402,000 | 24,398,000 | 6,075,000 | -18,818,000 | 136,101,000 | 89,467,000 | 17,538,000 | 0 | 0 | -22,791,000 | 59,557,000 | 33,891,000 | 74,718,000 | -35,141,000 | 43,597,000 | 31,554,000 | 9,141,000 | -6,012,000 | -891,000 | 170,224,000 | -23,753,000 | -48,106,000 | 199,711,000 | 201,995,000 | -14,463,000 | -1,643,000 | -37,190,000 | -312,992,000 | -178,503,000 | 282,631,000 | -258,490,000 | -324,412,000 | 551,334,000 | -51,363,000 | 88,039,000 | -889,239,000 | -108,930,000 | 4,096,000 | 54,695,000 | |||||||
cash flows from investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities, calls and principal repayments of investment securities available for sale | 67,962,000 | 99,521,000 | 171,222,000 | 198,304,000 | 146,343,000 | 113,323,000 | 94,795,000 | 72,206,000 | 86,649,000 | 69,648,000 | 56,014,000 | 58,750,000 | 5,564,000 | 4,350,000 | 4,902,000 | 2,945,000 | ||||||||||||||||||||||||||||||||
proceeds from maturities, calls and principal repayments of investment securities held to maturity | 86,522,000 | 69,058,000 | 74,159,000 | 74,547,000 | 70,464,000 | 72,327,000 | 76,541,000 | 81,610,000 | 50,073,000 | 44,213,000 | 45,876,000 | 8,559,000 | ||||||||||||||||||||||||||||||||||||
proceeds from sales of investment securities available for sale | 384,070,000 | 159,000 | 218,718,000 | 21,970,000 | 293,342,000 | 301,942,000 | 126,668,000 | 399,011,000 | 155,954,000 | 23,833,000 | 258,436,000 | 53,672,000 | 353,915,000 | 10,043,000 | 268,560,000 | 0 | 0 | 70,752,000 | 582,469,000 | 5,000 | 0 | 2,848,000 | 314,000 | 0 | 0 | 0 | 0 | 257,645,000 | 48,965,000 | |||||||||||||||||||
purchases of investment securities available for sale | -350,082,000 | -156,689,000 | -179,988,000 | -66,489,000 | -270,406,000 | -328,905,000 | -427,600,000 | -28,926,000 | -86,582,000 | -814,246,000 | -2,202,418,000 | -533,773,000 | -300,312,000 | -589,874,000 | -177,568,000 | -743,935,000 | -121,628,000 | -158,782,000 | 0 | 0 | -7,000,000 | -756,242,000 | 0 | -152,583,000 | -105,467,000 | -538,544,000 | 0 | 0 | -5,000,000 | -62,358,000 | -320,965,000 | -34,150,000 | -35,620,000 | 0 | ||||||||||||||
purchases of investment securities held to maturity | 0 | -14,022,000 | -111,000 | 0 | 0 | 0 | -73,074,000 | 0 | ||||||||||||||||||||||||||||||||||||||||
purchases of equity method investments | -140,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
origination of mortgage finance loans | -6,833,200,000 | -5,329,199,000 | -5,652,456,000 | -6,108,662,000 | -5,449,515,000 | -4,936,887,000 | ||||||||||||||||||||||||||||||||||||||||||
proceeds from repayments of mortgage finance loans | 6,681,785,000 | 5,287,252,000 | 5,579,087,000 | 5,863,833,000 | 5,397,709,000 | 4,880,422,000 | ||||||||||||||||||||||||||||||||||||||||||
net increase in loans and leases, excluding mortgage finance loans | -123,599,000 | -337,435,000 | -529,157,000 | -262,379,000 | -292,876,000 | 16,634,000 | ||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of loans and leases | 0 | 1,081,000 | 577,000 | 10,718,000 | 0 | 12,396,000 | 102,201,000 | 20,438,000 | 14,281,000 | 130,350,000 | 90,967,000 | 39,534,000 | ||||||||||||||||||||||||||||||||||||
purchases of loans | -75,980,000 | -106,020,000 | -77,171,000 | -70,578,000 | -43,241,000 | -7,403,000 | -6,788,000 | -101,735,000 | -588,124,000 | -12,550,000 | ||||||||||||||||||||||||||||||||||||||
purchases of bank-owned life insurance | 0 | -1,462,000 | 0 | 0 | 0 | -40,000,000 | 0 | -50,000,000 | 0 | 0 | -15,000,000 | -17,500,000 | -465,000 | -10,000,000 | 0 | |||||||||||||||||||||||||||||||||
proceeds from bank-owned life insurance | 532,000 | 5,102,000 | 0 | 2,547,000 | 2,387,000 | 176,000 | 0 | 1,418,000 | 54,500,000 | 727,000 | 0 | 2,286,000 | 3,671,000 | 5,850,000 | 0 | 0 | 0 | 0 | 0 | 529,000 | 0 | 0 | 0 | |||||||||||||||||||||||||
net (purchases of) proceeds from sale of fhlb, federal reserve bank, and other restricted stock | -3,832,000 | -544,000 | -2,759,000 | 8,786,000 | 9,481,000 | 377,000 | -1,507,000 | -50,537,000 | 11,747,000 | |||||||||||||||||||||||||||||||||||||||
purchases of bank premises and equipment | -86,000 | -686,000 | -499,000 | -256,000 | -318,000 | -418,000 | -69,000 | -367,000 | -24,000 | -130,000 | -3,459,000 | -267,000 | -46,000 | -274,000 | -195,000 | -106,000 | -14,000 | -298,000 | -511,000 | -4,017,000 | -87,000 | -127,000 | 3,692,000 | -5,052,000 | -204,000 | -141,000 | -433,000 | -736,000 | -340,000 | -268,000 | -410,000 | -451,000 | -1,079,000 | -195,000 | -1,158,000 | -520,000 | -1,665,000 | -640,000 | -970,000 | -829,000 | -1,396,000 | -1,054,000 | -290,000 | -785,000 | -1,152,000 | -406,000 | -996,000 | |
proceeds from sale of other real estate owned | 0 | 46,000 | 33,000 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of leased assets under lessor operating leases | 3,794,000 | 413,000 | 3,911,000 | 852,000 | 13,630,000 | 94,000 | 26,000 | 1,946,000 | 456,000 | 113,000 | 4,596,000 | 562,000 | 4,617,000 | -631,000 | ||||||||||||||||||||||||||||||||||
purchases of leased assets under lessor operating leases | -23,413,000 | -16,398,000 | -32,397,000 | -11,698,000 | -15,594,000 | -4,007,000 | -20,495,000 | -5,376,000 | -12,805,000 | -2,076,000 | -22,504,000 | -58,046,000 | -25,821,000 | -2,930,000 | -15,647,000 | -8,066,000 | -3,776,000 | -4,849,000 | -12,692,000 | -2,421,000 | -2,627,000 | -6,384,000 | -21,313,000 | -15,567,000 | -3,881,000 | -7,791,000 | ||||||||||||||||||||||
net cash from investing activities | -119,174,000 | -500,028,000 | -261,067,000 | -386,705,000 | -195,159,000 | -163,160,000 | 397,066,000 | 795,461,000 | 804,645,000 | 661,569,000 | -1,710,766,000 | -4,942,255,000 | -433,517,000 | 221,099,000 | -452,210,000 | -1,017,027,000 | -196,297,000 | 184,993,000 | 752,770,000 | -239,729,000 | -802,132,000 | 378,896,000 | -1,277,288,000 | 479,000 | 9,381,000 | 155,766,000 | -228,588,000 | -434,587,000 | -245,557,000 | -166,675,000 | -686,000 | -576,248,000 | -259,686,000 | -338,946,000 | 558,584,000 | -157,551,000 | 117,087,000 | -246,799,000 | ||||||||||
cash flows from financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||
net increase in deposits | 34,733,000 | 66,911,000 | 805,305,000 | 368,167,000 | -281,273,000 | 41,501,000 | -274,773,000 | 245,286,000 | 227,161,000 | -435,823,000 | 634,515,000 | 577,719,000 | 529,159,000 | -362,364,000 | -193,101,000 | 3,097,086,000 | 1,401,499,000 | 1,162,511,000 | 470,852,000 | -126,798,000 | 2,552,232,000 | -235,293,000 | -276,749,000 | 739,908,000 | 760,459,000 | 283,082,000 | -1,371,478,000 | 1,217,760,000 | 253,495,000 | 242,317,000 | -796,934,000 | 118,359,000 | 394,861,000 | -219,919,000 | 637,711,000 | 272,644,000 | 569,116,000 | 308,042,000 | 583,843,000 | 360,789,000 | 467,621,000 | 239,904,000 | 95,031,000 | 418,351,000 | 125,709,000 | 221,071,000 | 1,226,000 | |
proceeds from long-term borrowed funds from fhlb and frb | 60,000,000 | 100,000,000 | 0 | 80,000,000 | 0 | 0 | 0 | 2,565,000,000 | ||||||||||||||||||||||||||||||||||||||||
repayments of long-term borrowed funds from fhlb and frb | 0 | -100,000,000 | -75,000,000 | 0 | -340,000,000 | -510,000,000 | 0 | -1,015,000,000 | ||||||||||||||||||||||||||||||||||||||||
redemption of preferred stock | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
preferred stock dividends paid | -3,414,000 | -3,434,000 | -3,646,000 | -3,788,000 | -3,909,000 | -3,804,000 | -3,813,000 | -3,811,000 | -3,562,000 | -3,450,000 | -2,952,000 | -2,460,000 | -2,091,000 | -1,823,000 | -2,039,000 | -2,048,000 | -3,345,000 | -3,401,000 | -3,415,000 | -3,432,000 | -3,614,000 | -3,615,000 | -3,615,000 | -3,615,000 | -3,614,000 | -3,615,000 | -3,615,000 | -3,615,000 | -3,614,000 | -3,615,000 | -3,615,000 | -3,615,000 | -3,614,000 | -3,615,000 | -2,340,000 | -1,896,000 | -1,214,000 | |||||||||||
purchase of treasury stock | 0 | -5,641,000 | 0 | 0 | -39,806,000 | 0 | -21,510,000 | -6,310,000 | 0 | 0 | 0 | -571,000 | ||||||||||||||||||||||||||||||||||||
payments of employee taxes withheld from share-based awards | -2,465,000 | -9,815,000 | -302,000 | -161,000 | -3,563,000 | -1,426,000 | -4,000 | -56,000 | -93,000 | -2,280,000 | -815,000 | -52,000 | -441,000 | -3,755,000 | -1,367,000 | -1,907,000 | -306,000 | -1,988,000 | -920,000 | -76,000 | -135,000 | -932,000 | -366,000 | -156,000 | -316,000 | -894,000 | -11,000 | -113,000 | -587,000 | -962,000 | -1,789,000 | -2,172,000 | ||||||||||||||||
proceeds from issuance of common stock | 488,000 | 645,000 | 250,000 | 734,000 | 296,000 | 481,000 | 2,788,000 | 164,000 | 105,000 | 55,000 | 86,000 | 123,000 | 116,000 | 208,000 | 16,102,000 | 3,845,000 | 1,131,000 | 6,684,000 | 288,000 | 225,000 | 185,000 | 225,000 | 614,000 | 242,000 | 222,000 | 1,072,000 | 227,000 | 2,847,000 | 344,000 | 212,000 | 184,000 | 1,716,000 | 5,716,000 | 244,000 | 607,000 | 102,000 | 519,000 | 109,000 | 94,762,000 | |||||||||
net cash from financing activities | 31,841,000 | 48,666,000 | 825,574,000 | 401,742,000 | -463,449,000 | 36,752,000 | -268,417,000 | 223,611,000 | 768,696,000 | -359,188,000 | 940,961,000 | 5,678,635,000 | 512,385,000 | -234,409,000 | 507,079,000 | 986,019,000 | 257,836,000 | -788,001,000 | -508,686,000 | 299,797,000 | 919,326,000 | -651,764,000 | 1,039,665,000 | -254,979,000 | 251,624,000 | -155,784,000 | 581,738,000 | 611,135,000 | -45,264,000 | 482,931,000 | 287,898,000 | 74,882,000 | 335,594,000 | 246,031,000 | 366,113,000 | 297,709,000 | -103,929,000 | 212,844,000 | ||||||||||
net increase in cash and cash equivalents | 74,821,000 | -357,241,000 | 697,909,000 | 39,435,000 | -652,533,000 | -145,226,000 | 426,372,000 | 264,750,000 | 1,108,539,000 | 1,590,879,000 | 159,287,000 | -29,422,000 | -243,432,000 | 621,554,000 | -84,864,000 | -177,990,000 | 361,938,000 | -735,914,000 | 811,098,000 | 43,727,000 | 30,287,000 | 86,423,000 | -21,867,000 | 55,527,000 | -603,899,000 | 414,308,000 | 36,315,000 | 69,088,000 | -73,157,000 | -202,210,000 | -37,208,000 | -8,190,000 | 57,766,000 | -37,200,000 | 49,968,000 | 24,545,000 | -4,876,000 | 35,458,000 | 31,228,000 | 17,254,000 | 20,740,000 | |||||||
cash and cash equivalents – beginning | 0 | 3,785,931,000 | 0 | 0 | 3,846,346,000 | 0 | 0 | 455,806,000 | 0 | 0 | 518,032,000 | 0 | 0 | 693,354,000 | 0 | 0 | 212,505,000 | 0 | 0 | 0 | 62,135,000 | 0 | 0 | 0 | 146,323,000 | 0 | 20,000,000 | 0 | 244,709,000 | 0 | 0 | 264,593,000 | 0 | 0 | 371,023,000 | |||||||||||||
cash and cash equivalents – ending | 74,821,000 | 3,428,690,000 | 39,435,000 | -652,533,000 | 3,701,120,000 | 264,750,000 | 1,108,539,000 | 2,046,685,000 | 159,287,000 | -29,422,000 | 274,600,000 | 621,554,000 | -84,864,000 | 515,364,000 | -735,914,000 | 811,098,000 | 256,232,000 | 30,287,000 | 86,423,000 | -21,867,000 | 117,662,000 | -603,899,000 | 414,308,000 | 36,315,000 | 215,411,000 | -73,157,000 | -182,210,000 | 244,560,000 | 157,130,000 | -37,208,000 | 40,158,000 | 262,638,000 | -8,190,000 | 57,766,000 | 333,823,000 | |||||||||||||
non-cash investing and financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||
transfer of loans held for investment to held for sale | 468,000 | 30,920,000 | 0 | 52,611,000 | 240,465,000 | 16,000,000 | -28,000 | -10,669,000 | -16,434,000 | 44,258,000 | -714,000 | |||||||||||||||||||||||||||||||||||||
transfer of loans held for sale to held for investment | 1,196,000 | 135,815,000 | 1,971,000 | 2,016,000 | 2,336,000 | 858,000 | 786,000 | 0 | 0 | 0 | 0 | 129,691,000 | ||||||||||||||||||||||||||||||||||||
transfer of loans to other real estate owned | 0 | 0 | 31,000 | 131,000 | 160,000 | 177,000 | 0 | 57,000 | 13,000 | 272,000 | 320,000 | 793,000 | 2,246,000 | 159,000 | 4,835,000 | 3,489,000 | 1,935,000 | 3,352,000 | 2,559,000 | 2,382,000 | ||||||||||||||||||||||||||||
impairment loss on investment securities | 51,319,000 | 0 | 8,349,000 | 2,882,000 | 1,703,000 | |||||||||||||||||||||||||||||||||||||||||||
net income from continuing operations | 26,915,000 | 46,743,000 | 58,085,000 | 49,726,000 | 62,092,000 | 86,756,000 | 47,574,000 | 53,721,000 | 28,711,000 | 63,912,000 | 58,650,000 | 76,761,000 | 102,254,000 | 116,042,000 | 61,341,000 | 74,631,000 | 28,952,000 | 26,924,000 | ||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from continuing operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||
impairment loss on fixed assets and leases | 0 | 0 | 15,000 | 109,000 | 0 | 162,000 | ||||||||||||||||||||||||||||||||||||||||||
settlement of terminated fair value hedge derivatives | 0 | 0 | 0 | 4,630,000 | ||||||||||||||||||||||||||||||||||||||||||||
loss on sale of capital call lines of credit | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of consumer installment loans | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
net (purchases of) proceeds from sales of fhlb, federal reserve bank, and other restricted stock | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of fixed assets | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of other real estate owned | 0 | 0 | 20,000 | 0 | 0 | 77,000 | 0 | 1,792,000 | 393,000 | 0 | 998,000 | 232,000 | 450,000 | 109,000 | 224,000 | 86,000 | 1,141,000 | 2,812,000 | 1,619,000 | 1,983,000 | 2,154,000 | 445,000 | 3,361,000 | 1,178,000 | 2,844,000 | 195,000 | ||||||||||||||||||||||
net increase in short-term borrowed funds from the fhlb | 300,000,000 | -135,000,000 | 135,000,000 | -700,000,000 | 700,000,000 | 0 | 410,000,000 | -190,800,000 | -221,300,000 | -113,732,000 | -222,238,000 | 413,070,000 | -1,554,797,000 | 137,182,000 | 640,755,000 | 149,517,000 | -537,257,000 | 793,050,000 | 337,750,000 | 223,200,000 | -16,600,000 | -402,100,000 | ||||||||||||||||||||||||||
net increase in federal funds purchased | -365,000,000 | -405,000,000 | 70,000,000 | 625,000,000 | 75,000,000 | 0 | -365,000,000 | 115,000,000 | -430,000,000 | 680,000,000 | -705,000,000 | 167,000,000 | 165,000,000 | -33,000,000 | 18,000,000 | 201,000,000 | 187,000,000 | -105,000,000 | -90,000,000 | 40,000,000 | 8,000,000 | -3,000,000 | -65,000,000 | 132,000,000 | 10,000,000 | |||||||||||||||||||||||
repayments of other borrowings | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||
purchases of treasury stock | ||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents – beginning balance | ||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents – ending balance | ||||||||||||||||||||||||||||||||||||||||||||||||
supplementary cash flow information: | ||||||||||||||||||||||||||||||||||||||||||||||||
interest paid | 42,167,000 | 46,644,000 | 38,916,000 | 41,811,000 | 43,416,000 | 29,746,000 | 25,723,000 | 27,968,000 | 17,015,000 | 17,273,000 | 20,119,000 | 13,018,000 | 10,826,000 | 14,752,000 | 10,550,000 | 6,313,000 | 5,572,000 | 5,383,000 | 5,341,000 | 5,649,000 | 5,267,000 | |||||||||||||||||||||||||||
income taxes paid | 661,000 | 1,801,000 | 1,204,000 | -18,000 | 0 | 4,174,000 | 9,830,000 | 19,367,000 | 2,348,000 | 17,427,000 | 7,750,000 | 15,789,000 | 12,772,000 | 14,625,000 | 2,762,000 | 2,169,000 | 5,237,000 | 337,000 | 7,770,000 | 2,266,000 | 2,589,000 | |||||||||||||||||||||||||||
noncash investing and financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||
transfer of investment securities available for sale to held to maturity | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of investment securities held to maturity upon sale of consumer installment loans | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
net increase in short-term borrowed funds from fhlb | 0 | 0 | -300,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
repayments of other long-term borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||
net (gain) loss on sale of loans | ||||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on sale of loans | -68,000 | -2,000 | 244,000 | -83,000 | -289,000 | -1,790,000 | -2,070,000 | -2,788,000 | ||||||||||||||||||||||||||||||||||||||||
loss on sale of foreign subsidiaries | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
loss on cash flow hedge derivative terminations | 0 | 0 | 0 | 24,467,000 | ||||||||||||||||||||||||||||||||||||||||||||
settlement of terminated cash flow hedge derivatives | 0 | 0 | 0 | -27,156,000 | ||||||||||||||||||||||||||||||||||||||||||||
net cash from continuing operating activities | -295,847,000 | 108,998,000 | 49,084,000 | 116,940,000 | 21,016,000 | -14,801,000 | 88,941,000 | 200,384,000 | ||||||||||||||||||||||||||||||||||||||||
proceeds from sales of foreign subsidiaries | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
origination of mortgage warehouse loans | -4,671,419,000 | -5,280,641,000 | -5,401,925,000 | -4,702,988,000 | -5,397,386,000 | -7,104,182,000 | -8,526,235,000 | -7,938,526,000 | -10,742,121,000 | -12,893,188,000 | -14,401,135,000 | -16,998,093,000 | -19,183,320,000 | -18,190,825,000 | -13,782,142,000 | -9,791,820,000 | -9,615,025,000 | -9,921,046,000 | -7,206,674,000 | -5,039,797,000 | -5,469,586,000 | |||||||||||||||||||||||||||
proceeds from repayments of mortgage warehouse loans | 4,698,814,000 | 5,314,353,000 | 5,657,453,000 | 4,794,683,000 | 5,647,684,000 | 7,380,313,000 | 8,392,357,000 | 8,475,173,000 | 11,009,192,000 | 13,194,038,000 | 14,950,553,000 | 17,211,909,000 | 19,476,245,000 | 17,072,974,000 | 13,512,300,000 | 9,520,758,000 | 9,851,861,000 | 9,424,982,000 | 6,659,040,000 | 4,965,022,000 | 5,580,493,000 | |||||||||||||||||||||||||||
net increase in loans and leases, excluding mortgage warehouse loans | 680,679,000 | 296,698,000 | 553,608,000 | 736,616,000 | -293,209,000 | -346,892,000 | -1,452,714,000 | 159,706,000 | 1,131,671,000 | 1,825,679,000 | -818,198,000 | -486,158,000 | 512,480,000 | -218,000,000 | -4,690,068,000 | 174,971,000 | 245,826,000 | 15,857,000 | -24,597,000 | 1,932,000 | ||||||||||||||||||||||||||||
net proceeds from sales of (purchases of) fhlb, federal reserve bank, and other restricted stock | ||||||||||||||||||||||||||||||||||||||||||||||||
net cash from continuing investing activities | -213,304,000 | 14,959,000 | -1,188,739,000 | 88,672,000 | -1,120,386,000 | 1,388,942,000 | -943,163,000 | -526,654,000 | ||||||||||||||||||||||||||||||||||||||||
net increase in borrowed funds from ppp liquidity facility | -395,993,000 | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of other long-term borrowings | 0 | -523,000 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of non-controlling interest in bmt | 0 | 0 | 3,670,000 | 23,125,000 | ||||||||||||||||||||||||||||||||||||||||||||
net cash from continuing financing activities | 560,492,000 | 35,330,000 | 1,110,233,000 | -449,044,000 | 566,933,000 | -752,587,000 | 769,358,000 | 171,071,000 | ||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents from continuing operations | 51,341,000 | 159,287,000 | -29,422,000 | -243,432,000 | -532,437,000 | 621,554,000 | -84,864,000 | -155,199,000 | ||||||||||||||||||||||||||||||||||||||||
discontinued operations: | ||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents from discontinued operations | 0 | 0 | -22,791,000 | |||||||||||||||||||||||||||||||||||||||||||||
distribution of investment in bm technologies common stock | 0 | 0 | 32,983,000 | |||||||||||||||||||||||||||||||||||||||||||||
benefit for credit losses | 19,603,000 | 28,216,000 | -7,994,000 | 23,847,000 | 15,997,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of loans and leases | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from long-term borrowed funds from the fhlb | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from continuing operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on sale of investment securities | 2,135,000 | 3,029,000 | 1,063,000 | 49,000 | -6,063,000 | -1,812,000 | -23,566,000 | -43,000 | -11,707,000 | -4,354,000 | -3,974,000 | 0 | 1,000 | |||||||||||||||||||||||||||||||||||
origination of loans held for sale | -7,880,000 | -9,198,000 | -10,999,000 | -18,859,000 | -26,199,000 | -16,571,000 | -12,323,000 | -23,887,000 | -28,211,000 | -15,684,000 | -7,046,000 | -12,284,000 | -13,608,000 | -13,970,000 | -8,182,000 | -8,721,000 | 14,249,197,000 | -7,463,718,000 | -6,808,457,000 | -7,354,701,000 | -8,056,446,000 | -8,313,275,000 | -6,401,005,000 | -9,950,000,000 | -10,266,114,000 | -6,876,748,000 | -8,058,087,000 | -8,463,484,000 | -6,627,070,000 | -5,945,663,000 | -858,537,000 | -501,139,000 | -557,150,000 | |||||||||||||||
proceeds from the sale of loans held for sale | 9,406,000 | 9,990,000 | 24,813,000 | 15,567,000 | 20,564,000 | 11,988,000 | 17,122,000 | 25,990,000 | 25,264,000 | 13,797,000 | 7,948,000 | 11,340,000 | 16,524,000 | 11,366,000 | 8,225,000 | 8,740,000 | -14,111,995,000 | 7,407,600,000 | 6,728,331,000 | 7,522,650,000 | 8,197,934,000 | 7,893,674,000 | 6,834,060,000 | 9,847,150,000 | 9,932,876,000 | 6,693,763,000 | 8,327,348,000 | 8,190,819,000 | 6,285,952,000 | 5,229,675,000 | 6,353,872,000 | 6,113,541,000 | 5,041,313,000 | 750,870,000 | 500,270,000 | 587,425,000 | ||||||||||||
proceed from sales of foreign subsidiaries | ||||||||||||||||||||||||||||||||||||||||||||||||
purchase of loans | -137,814,000 | -24,632,000 | -206,330,000 | -517,710,000 | -652,176,000 | -620,300,000 | -117,036,000 | -44,461,000 | -15,402,000 | -17,733,000 | -193,363,000 | -531,051,000 | -80,779,000 | -426,298,000 | -129,289,000 | -50,148,000 | -69,232,000 | 0 | 0 | -90,802,000 | -171,839,000 | |||||||||||||||||||||||||||
net increase in borrowed funds from frb ppp liquidity facility | -3,865,865,000 | 581,709,000 | -1,130,860,000 | |||||||||||||||||||||||||||||||||||||||||||||
unsettled purchases of investment securities | 150,000,000 | -46,620,000 | 56,620,000 | 97,247,000 | ||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from by continuing operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||
net increase in long-term borrowed funds from the fhlb | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities, calls and principal repayments of investment securities | 224,809,000 | 85,668,000 | 110,402,000 | 62,348,000 | 78,274,000 | 54,406,000 | 24,079,000 | |||||||||||||||||||||||||||||||||||||||||
net proceeds from sale of fhlb, federal reserve bank, and other restricted stock | 15,205,000 | |||||||||||||||||||||||||||||||||||||||||||||||
benefit from credit losses on loans and leases | 13,890,000 | |||||||||||||||||||||||||||||||||||||||||||||||
loss upon acquisition of interest-only gnma securities | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities, calls and principal repayments on investment securities | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of subordinated long-term debt | ||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from sale of (purchases of) fhlb, federal reserve bank, and other restricted stock | -17,289,000 | 29,525,000 | 1,948,000 | 20,636,000 | ||||||||||||||||||||||||||||||||||||||||||||
transfer of multi-family loans held for sale to held for investment | ||||||||||||||||||||||||||||||||||||||||||||||||
benefit for credit losses on loans and leases | 3,291,000 | -2,919,000 | ||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on sale of sba and other loans | -2,185,000 | -2,071,000 | -3,752,000 | 620,000 | -256,000 | -170,000 | -298,000 | -166,000 | -138,000 | |||||||||||||||||||||||||||||||||||||||
amortization (accretion) of fair value discounts and premiums | -426,000 | -345,000 | -275,000 | -969,000 | -759,000 | -378,000 | 27,000 | |||||||||||||||||||||||||||||||||||||||||
non-cash operating and investing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||
unsettled sales of investment securities | -70,854,000 | 104,469,000 | ||||||||||||||||||||||||||||||||||||||||||||||
net increase in short-term borrowed funds from the frb | 175,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
impairment of software | ||||||||||||||||||||||||||||||||||||||||||||||||
net (gain) loss on sales of other real estate owned | 54,000 | 0 | 0 | -4,000 | 0 | -60,000 | -103,000 | |||||||||||||||||||||||||||||||||||||||||
valuation and other adjustments to other real estate owned | 31,000 | 0 | 29,000 | 46,000 | 37,000 | 41,000 | -651,000 | 343,000 | ||||||||||||||||||||||||||||||||||||||||
net proceeds from (purchases of) fhlb, federal reserve bank, and other restricted stock | -2,926,000 | 9,269,000 | -15,479,000 | -19,149,000 | -1,428,000 | 14,634,000 | 3,650,000 | 204,000 | ||||||||||||||||||||||||||||||||||||||||
purchases of university relationship intangible asset | ||||||||||||||||||||||||||||||||||||||||||||||||
exercise of warrants | 0 | 0 | 0 | 112,000 | 502,000 | |||||||||||||||||||||||||||||||||||||||||||
benefit from credit losses on loan and lease losses | 12,956,000 | 20,946,000 | 31,786,000 | |||||||||||||||||||||||||||||||||||||||||||||
acquisition of interest-only gnma securities securing a mortgage warehouse loan | ||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of residential reverse mortgage loans securing a mortgage warehouse loan | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from borrowed funds from ppp liquidity facility | ||||||||||||||||||||||||||||||||||||||||||||||||
supplementary cash flow information | ||||||||||||||||||||||||||||||||||||||||||||||||
benefit from loan and lease losses | 9,688,000 | 4,426,000 | 5,346,000 | 4,767,000 | 2,738,000 | 1,800,000 | ||||||||||||||||||||||||||||||||||||||||||
net amortization of investment securities premiums and discounts | 325,000 | 270,000 | 230,000 | 191,000 | 199,000 | 391,000 | 438,000 | 375,000 | 182,000 | 288,000 | 121,000 | 111,000 | 240,000 | 219,000 | 205,000 | 219,000 | 193,000 | 211,000 | 140,000 | 120,000 | 108,000 | 139,000 | ||||||||||||||||||||||||||
amortization of fair value discounts and premiums | 332,000 | 329,000 | 70,000 | 162,000 | 30,000 | 79,000 | 9,000 | 76,000 | -5,000 | -5,000 | ||||||||||||||||||||||||||||||||||||||
proceeds from sale of loans | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of loans | 13,173,000 | 12,570,000 | 16,468,000 | 11,776,000 | 7,479,000 | 105,448,000 | 74,341,000 | 10,581,000 | 6,946,000 | 43,359,000 | 7,479,000 | 141,437,000 | ||||||||||||||||||||||||||||||||||||
net proceeds from fhlb, federal reserve bank, and other restricted stock | ||||||||||||||||||||||||||||||||||||||||||||||||
purchase of university relationship intangible asset | ||||||||||||||||||||||||||||||||||||||||||||||||
unrealized (gain) loss on equity securities | 347,000 | -2,000 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities, calls and principal repayments of securities available for sale | 7,118,000 | 4,498,000 | 12,710,000 | 14,727,000 | 11,489,000 | 13,618,000 | 11,062,000 | 11,781,000 | 17,124,000 | 16,071,000 | 12,902,000 | 17,094,000 | 23,133,000 | 20,739,000 | ||||||||||||||||||||||||||||||||||
net purchases of fhlb, federal reserve bank, and other restricted stock | -44,471,000 | -16,810,000 | ||||||||||||||||||||||||||||||||||||||||||||||
supplementary cash flows information: | ||||||||||||||||||||||||||||||||||||||||||||||||
non-cash items: | ||||||||||||||||||||||||||||||||||||||||||||||||
university relationship intangible purchased not settled | 0 | 1,502,000 | ||||||||||||||||||||||||||||||||||||||||||||||
benefit from loan losses, net of change to fdic receivable and clawback liability | 831,000 | 2,352,000 | 535,000 | 3,050,000 | 88,000 | 786,000 | 1,980,000 | 2,094,000 | ||||||||||||||||||||||||||||||||||||||||
unrealized loss recognized on equity securities | 101,000 | 1,237,000 | ||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of investment securities | 0 | -5,349,000 | -26,000 | 16,000 | 0 | 0 | 0 | 0 | -8,797,000 | -209,000 | -1,318,000 | |||||||||||||||||||||||||||||||||||||
gain on sale of sba and other loans | -33,000 | -1,308,000 | -1,095,000 | -1,477,000 | -1,345,000 | |||||||||||||||||||||||||||||||||||||||||||
decrease in fdic loss sharing receivable net of clawback liability | ||||||||||||||||||||||||||||||||||||||||||||||||
net income on sales of other real estate owned | 0 | 5,000 | 65,000 | 15,000 | 175,000 | -107,000 | 441,000 | 74,000 | ||||||||||||||||||||||||||||||||||||||||
proceeds from maturities, calls and principal repayments on investment securities available for sale | 2,195,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net decrease (increase) in loans | 24,310,000 | |||||||||||||||||||||||||||||||||||||||||||||||
payments to the fdic on loss sharing agreements | ||||||||||||||||||||||||||||||||||||||||||||||||
purchases of leased assets under operating leases | ||||||||||||||||||||||||||||||||||||||||||||||||
acquisition and purchase of intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from long-term fhlb borrowings | 0 | 50,000,000 | 25,000,000 | 0 | 0 | 25,000,000 | ||||||||||||||||||||||||||||||||||||||||||
repayments of long-term debt | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt | ||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from issuance of preferred stock | 82,279,000 | 55,593,000 | 24,108,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||
payment of employee taxes withheld from share-based awards | ||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from issuance of common stock | ||||||||||||||||||||||||||||||||||||||||||||||||
benefit from loan losses | 2,924,000 | -784,000 | 2,117,000 | 750,000 | 4,620,000 | 1,100,000 | 2,900,000 | |||||||||||||||||||||||||||||||||||||||||
net increase in loans, excluding mortgage warehouse loans | ||||||||||||||||||||||||||||||||||||||||||||||||
purchase of leased assets under operating leases | -15,363,000 | -3,731,000 | -2,755,000 | |||||||||||||||||||||||||||||||||||||||||||||
(repayments of) proceeds from issuance of long-term debt | ||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sales of other real estate owned | -29,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net increase in loans | 28,289,000 | -46,969,000 | -39,323,000 | -338,478,000 | -195,502,000 | -387,069,000 | 26,310,000 | -218,447,000 | -448,956,000 | -260,538,000 | -197,076,000 | -148,554,000 | -261,391,000 | -235,636,000 | -141,965,000 | |||||||||||||||||||||||||||||||||
net proceeds from issuance of long-term debt | -10,000 | |||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain recognized on equity securities | -10,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net (purchases of) proceeds from fhlb, federal reserve bank, and other restricted stock | -24,384,000 | -7,307,000 | ||||||||||||||||||||||||||||||||||||||||||||||
supplementary cash flows information | ||||||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in fdic loss sharing receivable net of clawback liability | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
valuation and other adjustments to other real estate owned, net of fdic receivable | 0 | 67,000 | 208,000 | 23,000 | 1,068,000 | 23,000 | 170,000 | |||||||||||||||||||||||||||||||||||||||||
(payments to) reimbursements from the fdic on loss sharing agreements | -1,381,000 | -302,000 | ||||||||||||||||||||||||||||||||||||||||||||||
acquisition of disbursements business | ||||||||||||||||||||||||||||||||||||||||||||||||
transfer of loans held for investment to loans held for sale | -120,000 | |||||||||||||||||||||||||||||||||||||||||||||||
cash flows from operating activities of continuing operations | ||||||||||||||||||||||||||||||||||||||||||||||||
benefit from depreciation and amortization | 1,086,000 | 1,307,000 | 1,995,000 | 1,173,000 | 970,000 | 966,000 | 1,035,000 | 1,033,000 | 836,000 | 651,000 | 628,000 | 760,000 | 239,000 | 448,000 | 408,000 | |||||||||||||||||||||||||||||||||
share-based compensation | 1,512,000 | 1,641,000 | 1,819,000 | 1,705,000 | 1,689,000 | 1,357,000 | 1,339,000 | 1,416,000 | ||||||||||||||||||||||||||||||||||||||||
gain on sale of mortgages and other loans | -762,000 | -1,421,000 | -1,485,000 | -379,000 | -810,000 | -1,041,000 | -828,000 | -1,266,000 | ||||||||||||||||||||||||||||||||||||||||
net cash from operating activities of continuing operations | -401,595,000 | 453,657,000 | ||||||||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities of continuing operations | ||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities of continuing operations | -301,148,000 | -1,046,778,000 | ||||||||||||||||||||||||||||||||||||||||||||||
cash flows from financing activities of continuing operations | ||||||||||||||||||||||||||||||||||||||||||||||||
exercise and redemption of warrants | 0 | 420,000 | 50,000 | 953,000 | 118,000 | |||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities of continuing operations | 1,216,266,000 | 246,180,000 | ||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents of continuing operations | ||||||||||||||||||||||||||||||||||||||||||||||||
net cash from discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents of continuing operations | -346,941,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net cash flows from discontinued operations | 259,362,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -87,579,000 | -1,955,000 | ||||||||||||||||||||||||||||||||||||||||||||||
net decrease in short-term borrowed funds from the fhlb | ||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of disbursement business | ||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in federal funds purchased | ||||||||||||||||||||||||||||||||||||||||||||||||
increase in fdic loss sharing receivable net of clawback liability | 304,000 | 1,394,000 | ||||||||||||||||||||||||||||||||||||||||||||||
amortization (accretion) of fair value discounts | -114,000 | -1,426,000 | 600,000 | 32,000 | -451,000 | -1,328,000 | 1,374,000 | -50,000 | ||||||||||||||||||||||||||||||||||||||||
reimbursements from the fdic on loss sharing agreements | -320,000 | 1,437,000 | 3,006,000 | 758,000 | 2,370,000 | 3,866,000 | 1,324,000 | 118,000 | ||||||||||||||||||||||||||||||||||||||||
purchase of loan portfolios | ||||||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in accrued interest receivable and other assets | ||||||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in accrued interest payable and other liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||
benefit from loan losses, net of change to fdic receivable | 2,964,000 | |||||||||||||||||||||||||||||||||||||||||||||||
increase in fdic loss sharing receivable | -134,000 | -1,940,000 | -3,796,000 | 449,000 | -1,190,000 | |||||||||||||||||||||||||||||||||||||||||||
net increase in short-term borrowed funds | -98,000,000 | -2,000,000 | 101,000,000 | -147,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
loss contingency | 0 | 0 | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
gain on sale of loans | -358,000 | -50,000 | 71,000 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of sba loans | 376,000 | 3,464,000 | 436,000 | |||||||||||||||||||||||||||||||||||||||||||||
net proceeds from stock offering | -183,000 | |||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock under share-based compensation arrangements | ||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation | 926,000 | 831,000 | 704,000 | 350,000 | 738,000 | 528,000 | ||||||||||||||||||||||||||||||||||||||||||
gain on sale of sba loans | ||||||||||||||||||||||||||||||||||||||||||||||||
origination/purchase of loans held for sale | -4,732,671,000 | -6,409,695,000 | -6,035,469,000 | |||||||||||||||||||||||||||||||||||||||||||||
net increase in fdic loss sharing receivable | -239,000 | |||||||||||||||||||||||||||||||||||||||||||||||
impairment charges on other real estate owned | 148,000 | -76,000 | 89,000 | 468,000 | -957,000 | 957,000 | ||||||||||||||||||||||||||||||||||||||||||
change in investment in bank-owned life insurance | -615,000 | -567,000 | -476,000 | -402,000 | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities and principal repayments of investment securities held to maturity | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
purchase of loan portfolio | 0 | 0 | -155,306,000 | 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
net proceeds from (purchases of) fhlb, federal reserve bank, and other stock | ||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in short-term borrowed funds | -325,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from fhlb borrowings | -15,000,000 | 0 | 50,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt, net of deferred costs of 2,914 at september 30, 2013 | ||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents - beginning | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents - ending | 49,968,000 | |||||||||||||||||||||||||||||||||||||||||||||||
transfer of held to maturity investments to available for sale | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
decrease in accrued interest payable and other liabilities | 995,000 | -1,684,000 | -1,501,000 | |||||||||||||||||||||||||||||||||||||||||||||
net (purchases of) proceeds from restricted stock | 893,000 | -3,918,000 | ||||||||||||||||||||||||||||||||||||||||||||||
amortization of fair value discounts | 41,000 | |||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents — beginning | 186,016,000 | 0 | 0 | 73,570,000 | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents — ending | 181,140,000 | 35,458,000 | 31,228,000 | 90,824,000 | ||||||||||||||||||||||||||||||||||||||||||||
securities purchased not settled | 3,421,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net income available to common shareholders | ||||||||||||||||||||||||||||||||||||||||||||||||
net cash proceeds from bank acquisition | ||||||||||||||||||||||||||||||||||||||||||||||||
purchases of restricted stock | ||||||||||||||||||||||||||||||||||||||||||||||||
payment of preferred dividend | ||||||||||||||||||||||||||||||||||||||||||||||||
berkshire bancorp, inc. acquisition: | ||||||||||||||||||||||||||||||||||||||||||||||||
assets acquired | ||||||||||||||||||||||||||||||||||||||||||||||||
liabilities assumed | ||||||||||||||||||||||||||||||||||||||||||||||||
net income on sale of other real estate owned | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of sba loans | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from redemption (purchases of) restricted stock | ||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sale of other real estate owned | -60,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net increase in earnings on investment in bank owned life insurance | -346,000 | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities, calls and principal repayments on investment securities held to maturity | 38,203,000 | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds on sale of sba loans | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from bank owned life insurance | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from (purchases of) restricted stock | 858,000 | |||||||||||||||||||||||||||||||||||||||||||||||
non- cash items: | ||||||||||||||||||||||||||||||||||||||||||||||||
investment securities purchased but not settled | ||||||||||||||||||||||||||||||||||||||||||||||||
stock based compensation | ||||||||||||||||||||||||||||||||||||||||||||||||
bargain purchase gain on bank acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax expense | ||||||||||||||||||||||||||||||||||||||||||||||||
impairment charges on investment securities | ||||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on sales of other real estate owned | ||||||||||||||||||||||||||||||||||||||||||||||||
earnings on investment in bank owned life insurance | -276,000 | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities and principal repayments on investment securities held to maturity | ||||||||||||||||||||||||||||||||||||||||||||||||
sales of investment securities held to maturity | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from (purchases of) bank owned life insurance | ||||||||||||||||||||||||||||||||||||||||||||||||
purchase of restricted stock | -6,338,000 | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds and acquired cash in fdic assisted transactions | ||||||||||||||||||||||||||||||||||||||||||||||||
cash proceeds from acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||
payment of tarp preferred stock dividends | ||||||||||||||||||||||||||||||||||||||||||||||||
repayment of tarp | ||||||||||||||||||||||||||||||||||||||||||||||||
dividends on preferred stock | ||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of other real estate owned | ||||||||||||||||||||||||||||||||||||||||||||||||
increase in fdic loss sharing receivables | ||||||||||||||||||||||||||||||||||||||||||||||||
fair value adjustments on other real estate owned | ||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation expense | ||||||||||||||||||||||||||||||||||||||||||||||||
(increase) in accrued interest receivable and other assets | ||||||||||||||||||||||||||||||||||||||||||||||||
increase in other liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||
purchases of investment securities available-for-sale | ||||||||||||||||||||||||||||||||||||||||||||||||
purchases of investment securities held-to-maturity | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities and principal repayments on investment securities held-to-maturity | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities and principal repayments on investment securities available-for-sale | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of securities available-for-sale | ||||||||||||||||||||||||||||||||||||||||||||||||
net (increase) in loans | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the sale of sba loans | ||||||||||||||||||||||||||||||||||||||||||||||||
net cash proceeds from bank acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||
reimbursements under fdic loss sharing agreements | ||||||||||||||||||||||||||||||||||||||||||||||||
net increase in short-term borrowings | ||||||||||||||||||||||||||||||||||||||||||||||||
payment of preferred dividends | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock, net of issuance costs | ||||||||||||||||||||||||||||||||||||||||||||||||
income taxes (refund) paid | ||||||||||||||||||||||||||||||||||||||||||||||||
other real estate owned from bank acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||
loans from bank acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||
restricted stock from bank acquistions | ||||||||||||||||||||||||||||||||||||||||||||||||
fixed assets from bank acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||
bank owned life insurance from bank acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||
goodwill from bank acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||
deposits from bank acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock from bank acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||
common stock issued in bank acquisition | ||||||||||||||||||||||||||||||||||||||||||||||||
effect on common shares from reorganization | ||||||||||||||||||||||||||||||||||||||||||||||||
fair value adjustment for available for sale securities | ||||||||||||||||||||||||||||||||||||||||||||||||
acquisitions: | ||||||||||||||||||||||||||||||||||||||||||||||||
liabilitites assumed | ||||||||||||||||||||||||||||||||||||||||||||||||
see accompanying notes to the unaudited financial statements. | ||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to cash from operating activities: |
We provide you with 20 years of cash flow statements for Customers Bancorp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Customers Bancorp stock. Explore the full financial landscape of Customers Bancorp stock with our expertly curated income statements.
The information provided in this report about Customers Bancorp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.